Publication Results

Generate Report

Add publications by marking their checkboxes, or

Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer.

Mohammed A,  Janakiram NB,  Madka V,  Pathuri G,  Li Q,  Ritchie R,  Biddick L,  Kutche H,  Zhang Y,  Singh A,  Gali H,  Lightfoot S,  Steele VE,  Suen CS,  Rao CV
Oncotarget 2017 Nov 17;8(58):97822-97834
Major Program(s) or Research Group(s): Chemopreventive Agent DevelopmentProstate and Urologic Cancer
PubMed ID: 29228654
PMC ID: PMC5716694

A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.

Platz EA,  Kulac I,  Barber JR,  Drake CG,  Joshu CE,  Nelson WG,  Lucia MS,  Klein EA,  Lippman SM,  Parnes HL,  Thompson IM,  Goodman PJ,  Tangen CM,  De Marzo AM
Cancer Epidemiol Biomarkers Prev 2017 Oct;26(10):1549-1557
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 28754796
PMC ID: PMC5626618

Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.

Winchester DA,  Till C,  Goodman PJ,  Tangen CM,  Santella RM,  Johnson-Pais TL,  Leach RJ,  Xu J,  Zheng SL,  Thompson IM,  Lucia MS,  Lippman SM,  Parnes HL,  Isaacs WB,  De Marzo AM,  Drake CG,  Platz EA
Prostate 2017 Jun;77(8):908-919
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 28317149
PMC ID: PMC5400704

A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.

Gee JR,  Saltzstein DR,  Kim K,  Kolesar J,  Huang W,  Havighurst TC,  Wollmer BW,  Stublaski J,  Downs T,  Mukhtar H,  House MG,  Parnes HL,  Bailey HH
Cancer Prev Res (Phila) 2017 May;10(5):298-307
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 28325826
PMC ID: PMC5503683

Magnetic Resonance Imaging-Transrectal Ultrasound Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer.

Frye TP,  George AK,  Kilchevsky A,  Maruf M,  Siddiqui MM,  Kongnyuy M,  Muthigi A,  Han H,  Parnes HL,  Merino M,  Choyke PL,  Turkbey B,  Wood B,  Pinto PA
J Urol 2017 Mar;197(3 Pt 1):640-646
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 27613356
PMC ID: not available

A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma.

Apolo AB,  Karzai FH,  Trepel JB,  Alarcon S,  Lee S,  Lee MJ,  Tomita Y,  Cao L,  Yu Y,  Merino MJ,  Madan RA,  Parnes HL,  Steinberg SM,  Rodriguez BW,  Seon BK,  Gulley JL,  Arlen PM,  Dawson NA,  Figg WD,  Dahut WL
Clin Genitourin Cancer 2017 Feb;15(1):77-85
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 27328856
PMC ID: PMC6583922

Commentary: Prostate cancer screening-A long run for a short slide.

Parnes HL
Semin Oncol 2017 Feb;44(1):57-59
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 28395764
PMC ID: not available

Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice.

Seabloom DE,  Galbraith AR,  Haynes AM,  Antonides JD,  Wuertz BR,  Miller WA,  Miller KA,  Steele VE,  Suen CS,  O'Sullivan MG,  Ondrey FG
Cancer Prev Res (Phila) 2017 Feb;10(2):124-132
Major Program(s) or Research Group(s): Chemopreventive Agent DevelopmentProstate and Urologic Cancer
PubMed ID: 27993834
PMC ID: PMC5687250

Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins.

Kumar NB,  Pow-Sang J,  Spiess PE,  Park J,  Salup R,  Williams CR,  Parnes H,  Schell MJ
Oncotarget 2016 Oct 25;7(43):70794-70802
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 28053292
PMC ID: PMC5340117

Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women.

Provinciali N,  Suen C,  Dunn BK,  DeCensi A
Expert Rev Clin Pharmacol 2016 Oct;9(10):1263-1272
Major Program(s) or Research Group(s): BiometryProstate and Urologic Cancer
PubMed ID: 27583816
PMC ID: not available

Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden.

Montrose DC,  Zhou XK,  McNally EM,  Sue E,  Yantiss RK,  Gross SS,  Leve ND,  Karoly ED,  Suen CS,  Ling L,  Benezra R,  Pamer EG,  Dannenberg AJ
Cancer Prev Res (Phila) 2016 Sep;9(9):721-31
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 27432344
PMC ID: PMC5010963

Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.

Siddiqui MM,  George AK,  Rubin R,  Rais-Bahrami S,  Parnes HL,  Merino MJ,  Simon RM,  Turkbey B,  Choyke PL,  Wood BJ,  Pinto PA
J Natl Cancer Inst 2016 Sep;108(9)
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 27130933
PMC ID: PMC6059120

Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.

Price DK,  Chau CH,  Till C,  Goodman PJ,  Leach RJ,  Johnson-Pais TL,  Hsing AW,  Hoque A,  Parnes HL,  Schenk JM,  Tangen CM,  Thompson IM,  Reichardt JK,  Figg WD
Cancer 2016 Aug 1;122(15):2332-40
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 27164191
PMC ID: PMC4956504

TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.

Wood LV,  Fojo A,  Roberson BD,  Hughes MS,  Dahut W,  Gulley JL,  Madan RA,  Arlen PM,  Sabatino M,  Stroncek DF,  Castiello L,  Trepel JB,  Lee MJ,  Parnes HL,  Steinberg SM,  Terabe M,  Wilkerson J,  Pastan I,  Berzofsky JA
Oncoimmunology 2016 Aug;5(8):e1197459
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 27622067
PMC ID: PMC5007958

Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.

Gee JR,  Saltzstein DR,  Messing E,  Kim K,  Kolesar J,  Huang W,  Havighurst TC,  Harris L,  Wollmer BW,  Jarrard D,  House M,  Parnes H,  Bailey HH
Eur J Cancer Prev 2016 Jul;25(4):312-20
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 26313229
PMC ID: not available

Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.

Apolo AB,  Lindenberg L,  Shih JH,  Mena E,  Kim JW,  Park JC,  Alikhani A,  McKinney YY,  Weaver J,  Turkbey B,  Parnes HL,  Wood LV,  Madan RA,  Gulley JL,  Dahut WL,  Kurdziel KA,  Choyke PL
J Nucl Med 2016 Jun;57(6):886-92
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 26795292
PMC ID: PMC6599519

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.

Winchester DA,  Gurel B,  Till C,  Goodman PJ,  Tangen CM,  Santella RM,  Johnson-Pais TL,  Leach RJ,  Thompson IM,  Xu J,  Zheng SL,  Lucia MS,  Lippman SM,  Parnes HL,  Isaacs WB,  Drake CG,  De Marzo AM,  Platz EA
Prostate 2016 May;76(6):565-74
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 26771888
PMC ID: PMC4841624
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.

Murtola TJ,  Gurel B,  Umbehr M,  Lucia MS,  Thompson IM Jr,  Goodman PJ,  Kristal AR,  Parnes HL,  Lippman SM,  Sutcliffe S,  Peskoe SB,  Barber JR,  Drake CG,  Nelson WG,  De Marzo AM,  Platz EA
Cancer Epidemiol Biomarkers Prev 2016 Mar;25(3):463-9
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 26715424
PMC ID: PMC4779655
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets.

Shoemaker RH,  Suen CS,  Holmes CA,  Fay JR,  Steele VE
Semin Oncol 2016 Feb;43(1):189-197
Major Program(s) or Research Group(s): Chemopreventive Agent DevelopmentProstate and Urologic Cancer
PubMed ID: 26970137
PMC ID: PMC4789768

A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.

Karzai FH,  Apolo AB,  Cao L,  Madan RA,  Adelberg DE,  Parnes H,  McLeod DG,  Harold N,  Peer C,  Yu Y,  Tomita Y,  Lee MJ,  Lee S,  Trepel JB,  Gulley JL,  Figg WD,  Dahut WL
BJU Int 2015 Oct;116(4):546-55
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25407442
PMC ID: PMC6596291

Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.

Kumar NB,  Pow-Sang J,  Egan KM,  Spiess PE,  Dickinson S,  Salup R,  Helal M,  McLarty J,  Williams CR,  Schreiber F,  Parnes HL,  Sebti S,  Kazi A,  Kang L,  Quinn G,  Smith T,  Yue B,  Diaz K,  Chornokur G,  Crocker T,  Schell MJ
Cancer Prev Res (Phila) 2015 Oct;8(10):879-87
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25873370
PMC ID: PMC4596745

Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.

Nash SH,  Till C,  Song X,  Lucia MS,  Parnes HL,  Thompson IM Jr,  Lippman SM,  Platz EA,  Schenk J
Cancer Epidemiol Biomarkers Prev 2015 Oct;24(10):1507-15
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 26269564
PMC ID: PMC4592455

Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients.

Okoro C,  George AK,  Siddiqui MM,  Rais-Bahrami S,  Walton-Diaz A,  Shakir NA,  Rothwax JT,  Raskolnikov D,  Stamatakis L,  Su D,  Turkbey B,  Choyke PL,  Merino MJ,  Parnes HL,  Wood BJ,  Pinto PA
J Endourol 2015 Oct;29(10):1115-21
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25897467
PMC ID: PMC4593891

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.

Umbehr MH,  Gurel B,  Murtola TJ,  Sutcliffe S,  Peskoe SB,  Tangen CM,  Goodman PJ,  Thompson IM,  Lippman SM,  Lucia MS,  Parnes HL,  Drake CG,  Nelson WG,  De Marzo AM,  Platz EA
Prostate Cancer Prostatic Dis 2015 Sep;18(3):264-9
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25939516
PMC ID: PMC4537352

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Winchester DA,  Till C,  Goodman PJ,  Tangen CM,  Santella RM,  Johnson-Pais TL,  Leach RJ,  Xu J,  Zheng SL,  Thompson IM,  Lucia MS,  Lippmann SM,  Parnes HL,  Dluzniewski PJ,  Isaacs WB,  De Marzo AM,  Drake CG,  Platz EA
Prostate 2015 Sep;75(13):1403-18
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 26047319
PMC ID: PMC4536102

Omeprazole alone, or in combination with Aspirin inhibits azoxymethane-induced colon adenoma progression to adenocarcinoma and carcinoma invasion in F344 rat model

Mohammed Altaf,  Patlolla Jagan M. R.,  Zhang Yuting,  Biddick Laura,  Madka Venkateshwar,  Li Qian,  Lightfoot Stan,  Lubel Ronald,  Suen Chen S.,  Steele Vernon E.,  Rao Chinthalapally V.
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 2820
Major Program(s) or Research Group(s): Chemopreventive Agent DevelopmentProstate and Urologic Cancer
PubMed ID: not available
PMC ID: not available

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

Winchester Danyelle A.,  Till Cathee,  Goodman Phyllis J.,  Tangen Catherine M.,  Santella Regina M.,  Johnson-Pais Teresa L.,  Leach Robin J.,  Xu Jianfeng,  Zheng S. Lilly,  Thompson Ian M.,  Lucia M. Scott,  Lippmann Scott M.,  Parnes Howard L.,  Dluzniewski Paul J.,  Isaacs William B.,  De Marzo Angelo M.,  Drake Charles G.,  Platz Elizabeth A.
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 4605
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: not available
PMC ID: not available
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.

Nash SH,  Schenk JM,  Kristal AR,  Goodman PJ,  Lucia MS,  Parnes HL,  Thompson IM,  Lippman SM,  Song X,  Gurel B,  De Marzo A,  Platz EA
Cancer Prev Res (Phila) 2015 Jul;8(7):590-6
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25926387
PMC ID: PMC4491033

Pilot study on the bioactivity of vitamin d in the skin after oral supplementation.

Curiel-Lewandrowski C,  Tang JY,  Einspahr JG,  Bermudez Y,  Hsu CH,  Rezaee M,  Lee AH,  Tangrea J,  Parnes HL,  Alberts DS,  Chow HH
Cancer Prev Res (Phila) 2015 Jun;8(6):563-9
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25835512
PMC ID: PMC4511849

Assessment of treatment response using Computed Tomography (CT) tumor volume measurements and lesion number in metastatic urothelial carcinoma (mUC) patients (pts) receiving cabozantinib.

Allette Kimaada,  Pattanayak Puskar,  Steinberg Seth M.,  Parnes Howard,  Jackson Gloria,  Francis Deneise,  Lamping Elizabeth,  Folio Les,  Apolo Andrea Borghese
J Clin Oncol 2015 May 20;33(15):Abstract e15503
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: not available
PMC ID: not available

Evaluation of a new circulating tumor cell (CTC) platform to predict response and survival in metastatic urothelial carcinoma (UC) patients receiving cabozantinib (cabo).

Apolo Andrea Borghese,  Lee Min-Jung,  Tomita Yusuke,  Lee Sunmin,  Agarwal Piyush K.,  Jackson Gloria,  Francis Deneise C.,  Lamping Elizabeth,  Buford Lauren,  Tomita Saori,  Mackall Katherine,  Parnes Howard L.,  Dahut William L.,  Gulley James L.,  Trepel Jane B.
J Clin Oncol 2015 May 20;33(15):Abstract e15501
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: not available
PMC ID: not available

Association of NaF PET/CT findings with PSA and alkaline phosphatase in untreated castration-sensitive prostate cancer.

Couvillon Anna,  Turkbey Baris,  Lindenberg Maria Liza,  Choyke Peter L.,  Kaushal Aradhana,  Citrin Deborah E.,  Krauze Andra V.,  McNally Deborah,  McKinney Yolanda,  Martinez Mirna,  Han Hui,  Karzai Fatima,  Parnes Howard L.,  Pinto Peter A.,  Gulley James L.,  Dahut William L.,  Madan Ravi Amrit
J Clin Oncol 2015 May 20;33(15):Abstract 122
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: not available
PMC ID: not available

Effect of green tea catechins in prostate cancer chemoprevention.

Kumar Nagi B.,  Pow-Sang Julio,  Egan Kathleen,  Spiess Philippe E.,  Dickinson Shohreh I.,  Salup Raoul,  Helal Mohamed,  McLarty Jerry,  Williams Christopher R.,  Schreiber Fred James,  Parnes Howard,  Sebti Said,  Kazi Aslam,  Kang Loveleen,  Quinn Gwendolyn P.,  Smith Tiffany,  Yue Binglin,  Chornokur Ganna,  Crocker Theresa,  Schell Michael J.
J Clin Oncol 2015 May 20;33(15):Abstract 1572
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: not available
PMC ID: not available

Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.

Kolesar JM,  Pomplun M,  Havighurst T,  Stublaski J,  Wollmer B,  Kim K,  Tangrea JA,  Parnes HL,  House MG,  Gee J,  Messing E,  Bailey HH
J Oncol Pharm Pract 2015 Apr;21(2):128-31
Major Program(s) or Research Group(s): Prostate and Urologic CancerPhase 0/I/II Cancer Prevention Clinical Trials Program
PubMed ID: 24642450
PMC ID: PMC4261043

Association of NaF PET/CT findings with PSA and alkaline phosphatase in untreated castration-sensitive prostate cancer.

Couvillon Anna,  Turkbey Baris,  Lindenberg Maria Liza,  Choyke Peter L.,  Martinez Mirna,  McKinney Yolanda,  Kaushal Aradhana,  Citrin Deborah E.,  Krauze Andra,  McNally Deborah,  Giordano Luz,  Chun Guinevere,  Royce Cheryl,  Han Hui,  Karzai Fatima,  Parnes Howard L.,  Pinto Peter A.,  Gulley James L.,  Dahut William L.,  Madan Ravi Amrit
J Clin Oncol 2015 Mar 1;33(Suppl 7):Abstract 122
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: not available
PMC ID: not available

Generalizability of established prostate cancer risk variants in men of African ancestry.

Han Y,  Signorello LB,  Strom SS,  Kittles RA,  Rybicki BA,  Stanford JL,  Goodman PJ,  Berndt SI,  Carpten J,  Casey G,  Chu L,  Conti DV,  Rand KA,  Diver WR,  Hennis AJ,  John EM,  Kibel AS,  Klein EA,  Kolb S,  Le Marchand L,  Leske MC,  Murphy AB,  Neslund-Dudas C,  Park JY,  Pettaway C,  Rebbeck TR,  Gapstur SM,  Zheng SL,  Wu SY,  Witte JS,  Xu J,  Isaacs W,  Ingles SA,  Hsing A,  PRACTICAL Consortium,  ELLIPSE GAME-ON Consortium,  Easton DF,  Eeles RA,  Schumacher FR,  Chanock S,  Nemesure B,  Blot WJ,  Stram DO,  Henderson BE,  Haiman CA
Int J Cancer 2015 Mar 1;136(5):1210-7
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic CancerProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 25044450
PMC ID: PMC4268262
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease.

Hoque A,  Yao S,  Till C,  Kristal AR,  Goodman PJ,  Hsing AW,  Tangen CM,  Platz EA,  Stanczyk FZ,  Reichardt JK,  vanBokhoven A,  Neuhouser ML,  Santella RM,  Figg WD,  Price DK,  Parnes HL,  Lippman SM,  Ambrosone CB,  Thompson IM
Urology 2015 Mar;85(3):616-20
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25733274
PMC ID: PMC4348556

Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.

Zuo RC,  Apolo AB,  DiGiovanna JJ,  Parnes HL,  Keen CM,  Nanda S,  Dahut WL,  Cowen EW
JAMA Dermatol 2015 Feb;151(2):170-7
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25427282
PMC ID: not available

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Siddiqui MM,  Rais-Bahrami S,  Turkbey B,  George AK,  Rothwax J,  Shakir N,  Okoro C,  Raskolnikov D,  Parnes HL,  Linehan WM,  Merino MJ,  Simon RM,  Choyke PL,  Wood BJ,  Pinto PA
JAMA 2015 Jan 27;313(4):390-7
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25626035
PMC ID: PMC4572575

Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.

Christen WG,  Glynn RJ,  Gaziano JM,  Darke AK,  Crowley JJ,  Goodman PJ,  Lippman SM,  Lad TE,  Bearden JD,  Goodman GE,  Minasian LM,  Thompson IM Jr,  Blanke CD,  Klein EA
JAMA Ophthalmol 2015 Jan;133(1):17-24
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25232809
PMC ID: PMC4395006
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Chau CH,  Price DK,  Till C,  Goodman PJ,  Chen X,  Leach RJ,  Johnson-Pais TL,  Hsing AW,  Hoque A,  Tangen CM,  Chu L,  Parnes HL,  Schenk JM,  Reichardt JK,  Thompson IM,  Figg WD
PLoS One 2015;10(5):e0126672
Major Program(s) or Research Group(s): Prostate and Urologic Cancer
PubMed ID: 25955319
PMC ID: PMC4425512

Retention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOG-coordinated intergroup study S0000).

Arnold KB,  Hermos JA,  Anderson KB,  Minasian L,  Tangen CM,  Probstfield JF,  Cook ED
Cancer Epidemiol Biomarkers Prev 2014 Dec;23(12):2895-905
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25242051
PMC ID: PMC4257858
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Prevention and early detection of prostate cancer.

Cuzick J,  Thorat MA,  Andriole G,  Brawley OW,  Brown PH,  Culig Z,  Eeles RA,  Ford LG,  Hamdy FC,  Holmberg L,  Ilic D,  Key TJ,  La Vecchia C,  Lilja H,  Marberger M,  Meyskens FL,  Minasian LM,  Parker C,  Parnes HL,  Perner S,  Rittenhouse H,  Schalken J,  Schmid HP,  Schmitz-Dräger BJ,  Schröder FH,  Stenzl A,  Tombal B,  Wilt TJ,  Wolk A
Lancet Oncol 2014 Oct;15(11):e484-92
Major Program(s) or Research Group(s): Early DetectionLung and Upper Aerodigestive Cancer ;  Office of the Director ;  Prostate and Urologic Cancer
PubMed ID: 25281467
PMC ID: PMC4203149

Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?

Liang Y,  Ketchum NS,  Goodman PJ,  Klein EA,  Thompson IM Jr
J Urol 2014 Oct;192(4):1094-9
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24747090
PMC ID: PMC4194238
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Albanes D,  Till C,  Klein EA,  Goodman PJ,  Mondul AM,  Weinstein SJ,  Taylor PR,  Parnes HL,  Gaziano JM,  Song X,  Fleshner NE,  Brown PH,  Meyskens FL Jr,  Thompson IM
Cancer Prev Res (Phila) 2014 Sep;7(9):886-95
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 24961880
PMC ID: PMC4408535
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

Crowe FL,  Appleby PN,  Travis RC,  Barnett M,  Brasky TM,  Bueno-de-Mesquita HB,  Chajes V,  Chavarro JE,  Chirlaque MD,  English DR,  Gibson RA,  Giles GG,  Goodman GE,  Henning SM,  Kaaks R,  King IB,  Kolonel LN,  Kristal AR,  Neuhouser ML,  Park SY,  Severi G,  Siddiq A,  Stampfer MJ,  Stattin P,  Tangen CM,  Tjønneland A,  Trichopoulos D,  Tumino R,  Wilkens LR,  Key TJ,  Allen NE,  Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group
J Natl Cancer Inst 2014 Sep;106(9)
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25210201
PMC ID: PMC4188122
Clinical Trials: Prostate Cancer Prevention Trial (PCPT) ;  Selenium and Vitamin E Cancer Prevention Trial (SELECT)

A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Martinez EE,  Darke AK,  Tangen CM,  Goodman PJ,  Fowke JH,  Klein EA,  Abdulkadir SA
Cancer Prev Res (Phila) 2014 Sep;7(9):950-7
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24894197
PMC ID: PMC4154984
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Wolpin BM,  Rizzato C,  Kraft P,  Kooperberg C,  Petersen GM,  Wang Z,  Arslan AA,  Beane-Freeman L,  Bracci PM,  Buring J,  Canzian F,  Duell EJ,  Gallinger S,  Giles GG,  Goodman GE,  Goodman PJ,  Jacobs EJ,  Kamineni A,  Klein AP,  Kolonel LN,  Kulke MH,  Li D,  Malats N,  Olson SH,  Risch HA,  Sesso HD,  Visvanathan K,  White E,  Zheng W,  Abnet CC,  Albanes D,  Andreotti G,  Austin MA,  Barfield R,  Basso D,  Berndt SI,  Boutron-Ruault MC,  Brotzman M,  Büchler MW,  Bueno-de-Mesquita HB,  Bugert P,  Burdette L,  Campa D,  Caporaso NE,  Capurso G,  Chung C,  Cotterchio M,  Costello E,  Elena J,  Funel N,  Gaziano JM,  Giese NA,  Giovannucci EL,  Goggins M,  Gorman MJ,  Gross M,  Haiman CA,  Hassan M,  Helzlsouer KJ,  Henderson BE,  Holly EA,  Hu N,  Hunter DJ,  Innocenti F,  Jenab M,  Kaaks R,  Key TJ,  Khaw KT,  Klein EA,  Kogevinas M,  Krogh V,  Kupcinskas J,  Kurtz RC,  LaCroix A,  Landi MT,  Landi S,  Le Marchand L,  Mambrini A,  Mannisto S,  Milne RL,  Nakamura Y,  Oberg AL,  Owzar K,  Patel AV,  Peeters PH,  Peters U,  Pezzilli R,  Piepoli A,  Porta M,  Real FX,  Riboli E,  Rothman N,  Scarpa A,  Shu XO,  Silverman DT,  Soucek P,  Sund M,  Talar-Wojnarowska R,  Taylor PR,  Theodoropoulos GE,  Thornquist M,  Tjønneland A,  Tobias GS,  Trichopoulos D,  Vodicka P,  Wactawski-Wende J,  Wentzensen N,  Wu C,  Yu H,  Yu K,  Zeleniuch-Jacquotte A,  Hoover R,  Hartge P,  Fuchs C,  Chanock SJ,  Stolzenberg-Solomon RS,  Amundadottir LT
Nat Genet 2014 Sep;46(9):994-1000
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic CancerProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 25086665
PMC ID: PMC4191666
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).

Gritz ER,  Arnold KB,  Moinpour CM,  Burton-Chase AM,  Tangen CM,  Probstfield JF,  See WA,  Lieber MM,  Caggiano V,  Moody-Thomas S,  Szczepanek C,  Ryan A,  Carlin S,  Hill S,  Goodman PJ,  Padberg RM,  Minasian LM,  Meyskens FL,  Thompson IM Jr
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1638-48
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Community Clinical Oncology Program ;  Prostate and Urologic Cancer
PubMed ID: 25028457
PMC ID: PMC4119542
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.

Kristal AR,  Till C,  Song X,  Tangen CM,  Goodman PJ,  Neuhauser ML,  Schenk JM,  Thompson IM,  Meyskens FL Jr,  Goodman GE,  Minasian LM,  Parnes HL,  Klein EA
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1494-504
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Prostate and Urologic Cancer ;  Community Clinical Oncology Program
PubMed ID: 24732629
PMC ID: PMC4119495
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)